Stuttgart - Delayed Quote • EUR Bayer AG (BAYN.SG) Follow Compare 20.85 -0.21 (-1.00%) At close: January 24 at 9:59:02 PM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for BAYN.SG 1D 5D -1.16% 1M 10.77% 3M -18.57% 6M -22.53% YTD 8.05% 1Y -35.99% 5Y -73.16% All -65.43% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: BAYN.SG View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Agtech Seedlings: CH4 Global to expand methane-reducing cattle feed with Mitsubishi Here’s Why Bayer Aktiengesellschaft (BAYRY) Declined in Q4 Jury orders Bayer to pay $100 million over PCBs in Washington school Agtech seedlings: Bayer, European refinery to scale US biofuel production Bayer Secures End of Roundup Weedkiller Litigation in Australia Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen FDA Accepts Cytokinetics' Application for Cardiovascular Drug FDA Accepts Bayer's Application for Label Expansion of Nubeqa Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan Bayer acquires rights to Cytokinetics' heart drug in Japan